Immuno-oncology Therapy Market Size, Share, Growth, and Industry Analysis, By Types (Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines), By Applications Covered (Hospitals, Ambulatory Surgical Center, Others), Regional Insights and Forecast to 2035

Detailed TOC of Global Immuno-oncology Therapy Market Research Report 2023

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Immune System Modulators
1.2.5 Cancer Vaccines
1.3 Market by Application
1.3.1 Global Immuno-oncology Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-oncology Therapy Market Perspective (2018-2029)
2.2 Immuno-oncology Therapy Growth Trends by Region
2.2.1 Global Immuno-oncology Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immuno-oncology Therapy Historic Market Size by Region (2018-2023)
2.2.3 Immuno-oncology Therapy Forecasted Market Size by Region (2024-2029)
2.3 Immuno-oncology Therapy Market Dynamics
2.3.1 Immuno-oncology Therapy Industry Trends
2.3.2 Immuno-oncology Therapy Market Drivers
2.3.3 Immuno-oncology Therapy Market Challenges
2.3.4 Immuno-oncology Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-oncology Therapy Players by Revenue
3.1.1 Global Top Immuno-oncology Therapy Players by Revenue (2018-2023)
3.1.2 Global Immuno-oncology Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-oncology Therapy Revenue
3.4 Global Immuno-oncology Therapy Market Concentration Ratio
3.4.1 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Therapy Revenue in 2022
3.5 Immuno-oncology Therapy Key Players Head office and Area Served
3.6 Key Players Immuno-oncology Therapy Product Solution and Service
3.7 Date of Enter into Immuno-oncology Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-oncology Therapy Breakdown Data by Type
4.1 Global Immuno-oncology Therapy Historic Market Size by Type (2018-2023)
4.2 Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029)
5 Immuno-oncology Therapy Breakdown Data by Application
5.1 Global Immuno-oncology Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immuno-oncology Therapy Market Size (2018-2029)
6.2 North America Immuno-oncology Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Immuno-oncology Therapy Market Size by Country (2018-2023)
6.4 North America Immuno-oncology Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-oncology Therapy Market Size (2018-2029)
7.2 Europe Immuno-oncology Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Immuno-oncology Therapy Market Size by Country (2018-2023)
7.4 Europe Immuno-oncology Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-oncology Therapy Market Size (2018-2029)
8.2 Asia-Pacific Immuno-oncology Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Immuno-oncology Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-oncology Therapy Market Size (2018-2029)
9.2 Latin America Immuno-oncology Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Immuno-oncology Therapy Market Size by Country (2018-2023)
9.4 Latin America Immuno-oncology Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-oncology Therapy Market Size (2018-2029)
10.2 Middle East & Africa Immuno-oncology Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Immuno-oncology Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-oncology Therapy Introduction
11.1.4 Amgen Revenue in Immuno-oncology Therapy Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-oncology Therapy Introduction
11.2.4 AstraZeneca Revenue in Immuno-oncology Therapy Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-oncology Therapy Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Detail
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-oncology Therapy Introduction
11.4.4 Eli-Lilly Revenue in Immuno-oncology Therapy Business (2018-2023)
11.4.5 Eli-Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-oncology Therapy Introduction
11.5.4 Roche Revenue in Immuno-oncology Therapy Business (2018-2023)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-oncology Therapy Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-oncology Therapy Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Detail
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-oncology Therapy Introduction
11.7.4 Janssen Biotech Revenue in Immuno-oncology Therapy Business (2018-2023)
11.7.5 Janssen Biotech Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-oncology Therapy Introduction
11.8.4 Merck Revenue in Immuno-oncology Therapy Business (2018-2023)
11.8.5 Merck Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-oncology Therapy Introduction
11.9.4 Novartis Revenue in Immuno-oncology Therapy Business (2018-2023)
11.9.5 Novartis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-oncology Therapy Introduction
11.10.4 Pfizer Revenue in Immuno-oncology Therapy Business (2018-2023)
11.10.5 Pfizer Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-oncology Therapy Introduction
11.11.4 Sanofi Revenue in Immuno-oncology Therapy Business (2018-2023)
11.11.5 Sanofi Recent Development
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Detail
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-oncology Therapy Business (2018-2023)
11.12.5 Spectrum Pharmaceuticals Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-oncology Therapy Introduction
11.13.4 Takeda Revenue in Immuno-oncology Therapy Business (2018-2023)
11.13.5 Takeda Recent Development
11.14 BioNTech SE
11.14.1 BioNTech SE Company Detail
11.14.2 BioNTech SE Business Overview
11.14.3 BioNTech SE Immuno-oncology Therapy Introduction
11.14.4 BioNTech SE Revenue in Immuno-oncology Therapy Business (2018-2023)
11.14.5 BioNTech SE Recent Development
11.15 Allogene Therapeutics
11.15.1 Allogene Therapeutics Company Detail
11.15.2 Allogene Therapeutics Business Overview
11.15.3 Allogene Therapeutics Immuno-oncology Therapy Introduction
11.15.4 Allogene Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2023)
11.15.5 Allogene Therapeutics Recent Development
11.16 IMAB-I-Mab Biopharma Co., Ltd.
11.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Detail
11.16.2 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
11.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Introduction
11.16.4 IMAB-I-Mab Biopharma Co., Ltd. Revenue in Immuno-oncology Therapy Business (2018-2023)
11.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Development
11.17 Arcus Biosciences
11.17.1 Arcus Biosciences Company Detail
11.17.2 Arcus Biosciences Business Overview
11.17.3 Arcus Biosciences Immuno-oncology Therapy Introduction
11.17.4 Arcus Biosciences Revenue in Immuno-oncology Therapy Business (2018-2023)
11.17.5 Arcus Biosciences Recent Development
11.18 Gritstone Oncology
11.18.1 Gritstone Oncology Company Detail
11.18.2 Gritstone Oncology Business Overview
11.18.3 Gritstone Oncology Immuno-oncology Therapy Introduction
11.18.4 Gritstone Oncology Revenue in Immuno-oncology Therapy Business (2018-2023)
11.18.5 Gritstone Oncology Recent Development
11.19 Autolus Therapeutics
11.19.1 Autolus Therapeutics Company Detail
11.19.2 Autolus Therapeutics Business Overview
11.19.3 Autolus Therapeutics Immuno-oncology Therapy Introduction
11.19.4 Autolus Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2023)
11.19.5 Autolus Therapeutics Recent Development
11.20 Rubius Therapeutics
11.20.1 Rubius Therapeutics Company Detail
11.20.2 Rubius Therapeutics Business Overview
11.20.3 Rubius Therapeutics Immuno-oncology Therapy Introduction
11.20.4 Rubius Therapeutics Revenue in Immuno-oncology Therapy Business (2018-2023)
11.20.5 Rubius Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details